iMTA
/ news

iMTA News

Keep yourself up to speed on developments and major publications at iMTA

iMTA April newsletter 2018

Our April 2018 newsletter is online. Find it here.

In this newsletter we highlight:

  • Updates on our endeavors in impact investing in life sciences
  • Start of a collaboration with Malta to redesign market access evaluations
  • Enrollment in our epilepsy seizure dog trial
  • Closing of the prostate cancer registry
Costs of traztuzumab and rituximab HER2pos

The aim of this study was to investigate healthcare and societal costs associated with SC injections and IV infusions of two oncology drugs (i.e. trastuzumab and rituximab) in The Netherlands. Find the abstract here.

iMTA newletter October 2017

Find our October 2017 newsletter here in which we report on our ISPOR presence (presenting schedule here), our new trial in epilepsy support dogs, our new H2020 project in the cost-effectiveness of self-management and more.

Vacancy #3

We are looking for a secretary, 16 hours a week. Speaking Dutch is a requirement.

Please read the vacancy text here and apply before the 22nd of September 2017. Job interviews will be held the last week of September.

 

Looking forward to meeting you!

iMTA July newsletter

The iMTA july newsletter is now online

Please find the newsletter here

Topics

  • A new cost-effectiveness threshold?
  • Impact of the new guidelines on cost-effectiveness in The Netherlands
  • Will personalized medicine reduce expenditures?
  • EMA parallel assessment with EUnetHTA
iMTA Newsletter November 2016

Please find our November newsletter here.

Containing information about:

  • The “When is it too expensive”? conference on the 9th of February 2016
  • The new costing tool
  • New publications
iMTA newsletter October 2016

Find the newsletter here:

With updates on:

– ISPOR: highlighted activities
– Selection of HTA publications online since the summer
– Collaboration with Karolinska Institutet
– EuroQoL meeting Berlin: Improved DCE’s, EQ-5D respiratory bolt-on, and patient preferences
– PhD dissertations: Last dissertations of the year on real world evidence and Pompe disease

Newsletter June 2016

The iMTA newletter of june 2016 is online. Please find it here.

In this issue:
– Measuring productivity losses, now in 13 languages
– Free iMTA tool online to assess severity of disease (‘ziektelast’)
– COPD burden of disease
– Updated version of PAID for indirect medical costs
– Vacancy
– PhD theses completed

Newsletter April 2016

The iMTA is involved in many health economic projects, with both public and private partners. However, our core research interest is to advance research methodology in our field. In this newsletter we highlight a selection of our publications in Q1 of 2016 that contribute to improved decision-making in health care.

In this issue:
Preventing Dementia
The new Dutch tariff for EQ-5D-5L
Cost-effectiveness of MDFT
A practical guide for setting up patient registries
Future costs and fixed health care budgets
iMTA productivity costs questionnaire
Maximum reimbursable prices
Practical model validation tool
Completed PhD theses

Please redirect here for our April 2016 newsletter.